Recombinant erythroid Kruppel-like factor fused to GATA1 up-regulates delta- and gamma-globin expression in erythroid cells

Blood

Volumn 117, Issue 11, 2011, Pages 3045-3052

  Zhu, Jianqiong ^a   Chin, Kyung ^a   Aerbajinai, Wulin ^a   Trainor, Cecelia ^b   Gao, Peter ^a   Rodgers, Griffin P ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; DELTA GLOBIN; ERYTHROID KRUPPEL LIKE FACTOR; GAMMA GLOBIN; HEMOGLOBIN A; HEMOGLOBIN F; HYBRID PROTEIN; LENTIVIRUS VECTOR; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR GATA 1;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; ERYTHROID CELL; GENE MUTATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; RNA TRANSCRIPTION; TRANSACTIVATION; UPREGULATION;

EID: 79953076380     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-07-294751     Document Type: Article

References (42)

1. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704-712. (Pubitemid 32776838)
2. Platt OS. Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med. 2008;358(13):1362-1369.
3. Hsieh MM, Tisdale TJ, Rodgers GP. Hemolytic anemia: thalassemias and sickle cell disease. In: Rodgers GP, Young NS, eds. Bethesda Handbook of Clinical Hematology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:35-54.
4. Rodgers GP, Saunthararajah Y. Advances in experimental treatment of beta-thalassaemia. Expert Opin Investig Drugs. 2001;10(5):925-934.
5. Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med. 1990;322(15):1037-1045. (Pubitemid 20146662)
6. Weatherall DJ. Pathophysiology of thalassaemia. Baillieres Clin Haematol. 1998;11(1):127-146. (Pubitemid 29039020)
7. Poillon WN, Kim BC, Rodgers GP, Noguchi CT, Schechter AN. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. Proc Natl Acad Sci U S A. 1993;90(11):5039-5043. (Pubitemid 23182971)
8. Dover GJ, Boyer SH, Charache S, Heintzelman K. Individual variation in the production and survival of F cells in sickle-cell disease. N Engl J Med. 1978;299(26):1428-1435.
9. Heller P, Yakulis V. The distribution of hemoglobin A2. Ann N Y Acad Sci. 1969;165(1):54-59.
10. Tang DC, Ebb D, Hardison RC, Rodgers GP. Restoration of the CCAAT box or insertion of the CACCC motif activates [corrected] delta-globin gene expression. Blood. 1997;90(1):421-427. (Pubitemid 27276588)
11. Tang DC, Rodgers GP. Activation of the human delta-globin gene promoter in primary adult erythroid cells. Br J Haematol. 1998;103(3):835-838. (Pubitemid 28545326)
12. Donze D, Jeancake PH, Townes TM. Activation of delta-globin gene expression by erythroid Krupple-like factor: a potential approach for gene therapy of sickle cell disease. Blood. 1996;88(10):4051-4057. (Pubitemid 26383131)
13. Bieker JJ, Southwood CM. The erythroid Kruppel-like factor transactivation domain is a critical component for cell-specific inducibility of a beta-globin promoter. Mol Cell Biol. 1995;15(2):852-860.
14. Evans T, Reitman M, Felsenfeld G. An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc Natl Acad Sci U S A. 1988;85(16):5976-5980.
15. Martin DI, Orkin SH. Transcriptional activation and DNA binding by the erythroid factor GF-1/NFE-1/Eryf 1. Genes Dev. 1990;4(11):1886-1898. (Pubitemid 120012590)
16. Newton A, Mackay J, Crossley M. The N-terminal zinc finger of the erythroid transcription factor GATA-1 binds GATC motifs in DNA. J Biol Chem. 2001;276(38):35794-35801.
17. Ghirlando R, Trainor CD. Determinants of GATA-1 binding to DNA: the role of non-finger residues. J Biol Chem. 2003;278(46):45620-45628. (Pubitemid 37432704)
18. Matsuda M, Sakamoto N, Fukumaki Y. Delta-thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the delta-globin gene promoter. Blood. 1992;80(5):1347-1351.
19. Ristaldi MS, Casula S, Porcu S, Marongiu MF, Pirastu M, Cao A. Activation of the delta-globin gene by the beta-globin gene CACCC motif. Blood Cells Mol Dis. 1999;25(3-4):193-209. (Pubitemid 29521421)
20. Ferreira R, Ohneda K, Yamamoto M, Philipsen S. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol. 2005;25(4):1215- 1227. (Pubitemid 40204902)
21. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997;16(13):3965-3973. (Pubitemid 27281012)
22. Weiss MJ, Orkin SH. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci U S A. 1995;92(21):9623-9627.
23. Zoueva OP, Rodgers GP. Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell line. Exp Hematol. 2004;32(8):700-708. (Pubitemid 39092735)
24. Harju-Baker S, Costa FC, Fedosyuk H, Neades R, Peterson KR. Silencing of Agamma-globin gene expression during adult definitive erythropoiesis mediated by GATA-1-FOG-1-Mi2 complex binding at the -566 GATA site. Mol Cell Biol. 2008;28(10):3101-3113.
25. Chen Z, Luo HY, Basran RK, et al. A T-to-G transversion at nucleotide -567 upstream of HBG2 in a GATA-1 binding motif is associated with elevated hemoglobin F. Mol Cell Biol. 2008;28(13):4386-4393. (Pubitemid 351904960)
26. Yao X, Kodeboyina S, Liu L, et al. Role of STAT3 and GATA-1 interactions in gamma-globin gene expression. Exp Hematol. 2009;37(8):889-900.
27. Asano H, Stamatoyannopoulos G. Activation of beta-globin promoter by erythroid Kruppel-like factor. Mol Cell Biol. 1998;18(1):102-109. (Pubitemid 28021022)
28. Tang DC, Zhu J, Liu W, et al. The hydroxyurea-induced small GTP-binding protein SAR modulates gamma-globin gene expression in human erythroid cells. Blood. 2005;106(9):3256-3263. (Pubitemid 41565927)
29. Xiao H, Zhu P, Liu B, et al. Generation and characterization of human delta-globin-specific monoclonal antibodies. Blood Cells Mol Dis. 2010;44(3):127-132.
30. Donze D, Townes TM, Bieker JJ. Role of erythroid Kruppel-like factor in human gamma- to beta-globin gene switching. J Biol Chem. 1995;270(4):1955-1959.
31. Bank A. Regulation of human fetal hemoglobin: new players, new complexities. Blood. 2006;107(2):435-443. (Pubitemid 43076362)
32. Franco RS, Yasin Z, Palascak MB, Ciraolo P, Joiner CH, Rucknagel DL. The effect of fetal hemoglobin on the survival characteristics of sickle cells. Blood. 2006;108(3):1073-1076. (Pubitemid 44154647)
33. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11-16.
34. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-1644.
35. Gregory RC, Taxman DJ, Seshasayee D, Kensinger MH, Bieker JJ, Wojchowski DM. Functional interaction of GATA1 with erythroid Kruppel-like factor and Sp1 at defined erythroid promoters. Blood. 1996;87(5):1793-1801.
36. Merika M, Orkin SH. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol Cell Biol. 1995;15(5):2437-2447.
37. Zhang L, Spratt SK, Liu Q, et al. Synthetic zinc finger transcription factor action at an endogenous chromosomal site. Activation of the human erythropoietin gene. J Biol Chem. 2000;275(43):33850-33860.
38. Gräslund T, Li X, Magnenat L, Popkov M, Barbas CF III. Exploring strategies for the design of artificial transcription factors: targeting sites proximal to known regulatory regions for the induction of gamma-globin expression and the treatment of sickle cell disease. J Biol Chem. 2005;280(5):3707-3714. (Pubitemid 40223838)
39. Visser AE, Verschure PJ, Gommans WM, Haisma HJ, Rots MG. Step into the groove: engineered transcription factors as modulators of gene expression. Adv Genet. 2006;56:131-161. (Pubitemid 43776134)
40. Manwani D, Galdass M, Bieker JJ. Altered regulation of beta-like globin genes by a redesigned erythroid transcription factor. Exp Hematol. 2007;35(1):39-47. (Pubitemid 46014372)
41. Bank A. On the road to gene therapy for beta-thalassemia and sickle cell anemia. Pediatr Hematol Oncol. 2008;25(1):1-4. (Pubitemid 351168917)
42. Persons DA. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders. Hematology Am Soc Hematol Educ Program. 2009:690-697.